Significant correlations of E-cadherin, catenin, and CD44 variant form expression with carcinoma cell differentiation and prognosis of extrahepatic bile duct carcinomas
- PMID: 11554165
- DOI: 10.1309/VV6D-3GAH-VEJM-DUJT
Significant correlations of E-cadherin, catenin, and CD44 variant form expression with carcinoma cell differentiation and prognosis of extrahepatic bile duct carcinomas
Abstract
To clarify the relation between alteration of expression of cell adhesion molecules and progression of extrahepatic bile duct carcinomas. 55 cases were immunohistochemically examined for E-cadherin, alpha-catenin, beta-catenin, and CD44, with additional reverse transcription-polymerase chain reaction and Southern blotting hybridization (RT-PCR/SBH) assays. Levels of E-cadherin, alpha-catenin, and beta-catenin proteins were lower in carcinomas than in normal mucosa, while CD44 variants 3 and 6 were upregulated. Well-differentiated carcinoma showed higher expression of E-cadherin and alpha-catenin than moderately to poorly differentiated types. Macroscopically papillary lesions had higher expression of E-cadherin than their nonpapillary counterparts. RT-PCR/SBH for CD44 revealed the CD44 variant form to be more prevalent in carcinoma than in normal mucosa, correlating with the immunohistochemical results, and with more exon variety. The Cox proportional hazards test identified histologic type and E-cadherin expression as prognostic factors. Among the examined molecules, E-cadherin was especially related to papillary mass formation and a good prognosis.
Similar articles
-
Lack of CD44 variant 6 expression in advanced extrahepatic bile duct/ampullary carcinoma.Cancer. 1999 Nov 1;86(9):1691-9. Cancer. 1999. PMID: 10547541
-
Expression of beta-catenin, alpha-catenin, and E-cadherin in Barrett's esophagus and esophageal adenocarcinomas.Mod Pathol. 1998 Sep;11(9):805-13. Mod Pathol. 1998. PMID: 9758359
-
An immunohistochemical examination of the expression of E-cadherin, alpha- and beta/gamma-catenins, and alpha2- and beta1-integrins in invasive breast cancer.J Pathol. 1999 Apr;187(5):523-9. doi: 10.1002/(SICI)1096-9896(199904)187:5<523::AID-PATH296>3.0.CO;2-3. J Pathol. 1999. PMID: 10398116
-
Defective E-cadherin/catenin complexes in human cancer.Virchows Arch. 2001 Dec;439(6):725-51. doi: 10.1007/s004280100516. Virchows Arch. 2001. PMID: 11787845 Review.
-
The cadherin-catenin superfamily in endocrine tumors.Endocr Pathol. 2001 Spring;12(1):1-13. doi: 10.1385/ep:12:1:01. Endocr Pathol. 2001. PMID: 11478263 Review.
Cited by
-
Silencing of CD44 by siRNA suppressed invasion, migration and adhesion to matrix, but not secretion of MMPs, of cholangiocarcinoma cells.Clin Exp Metastasis. 2011 Dec;28(8):827-39. doi: 10.1007/s10585-011-9414-8. Epub 2011 Aug 11. Clin Exp Metastasis. 2011. PMID: 21833756
-
Recent advances in the regulation of cholangiocyte proliferation and function during extrahepatic cholestasis.Dig Liver Dis. 2010 Apr;42(4):245-52. doi: 10.1016/j.dld.2010.01.008. Epub 2010 Feb 13. Dig Liver Dis. 2010. PMID: 20153989 Free PMC article. Review.
-
Bench to bedside and back again: molecular mechanisms of alpha-catenin function and roles in tumorigenesis.Semin Cancer Biol. 2008 Feb;18(1):53-64. doi: 10.1016/j.semcancer.2007.08.003. Epub 2007 Sep 4. Semin Cancer Biol. 2008. PMID: 17945508 Free PMC article. Review.
-
The prognostic significance of E-cadherin expression in laryngeal squamous-cell carcinoma: a systematic review.Acta Otorhinolaryngol Ital. 2018 Dec;38(6):504-510. doi: 10.14639/0392-100X-2106. Epub 2018 Nov 9. Acta Otorhinolaryngol Ital. 2018. PMID: 30499566 Free PMC article.
-
Evaluation of the prognostic value and functional roles of CD44v6 in gastric cancer.J Cancer Res Clin Oncol. 2015 Oct;141(10):1809-17. doi: 10.1007/s00432-015-1964-8. Epub 2015 Mar 26. J Cancer Res Clin Oncol. 2015. PMID: 25809905 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous